A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
Clinical trial NCT07023302 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07023302
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-19
- Primary completion
- 2029-02-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.